medline.ch Onkologie Blut

	Genetic prognostic markers in LymphGen-unclassifiable diffuse large B cell lymphoma. Int J Hematol Kanemasa Y, Sadato D, Isogai M, Ogawa M, Hirama C, Kawaji H, Yamaguchi T, Harada Y, Hishima T, Oboki K, Shimoyama T. PMID: 40938575 [PubMed - as supplied by publisher]
	Real-World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL-Chile Study. Cancer Med Espinoza M, Rojas-Vallejos J, Rodríguez N, Guerrero G, López M, Aranguiz N, Conte G, Samaniego F, Quinteros N, Astete D, Carcamo L, Flores C, Huerta X, Chandía M, Valenzuela J, Navarrete M, Flores Y, Larrazabal A, Zapata E, Jerez J. PMID: 40938298 [PubMed - in process]
	Concomitant Diagnosis and Therapeutic Response of Large-vessel Vasculitis and Hodgkin Lymphoma on 18F-FDG PET/CT. Clin Nucl Med Habouzit V, Peoc'h M, Nathalie P, Chalayer E, Cathebras P. PMID: 40938194 [PubMed - as supplied by publisher]
	Association Between Molecular Profile and Outcome After Intensive Chemotherapy in Patients >â€‰60â€‰Years With Secondary and/or Adverse Cytogenetics Acute Myeloid Leukemia-A FILO Study. Am J Hematol Orvain C, Bouvier A, Bidet A, Dumas PY, Bertoli S, Haddaoui L, Blanchet O, Thépot S, Tanguy-Schmidt A, Luque Paz D, Pigneux A, Delabesse E, Recher C, Hunault M. PMID: 40937842 [PubMed - as supplied by publisher]
	The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial. Front Oncol Efficace F, Cannella L, Capodanno I, Sancetta R, Porcu V, Lunghi M, Biagi A, Castagnetti F, Caocci G, Baldi T, Marasca R, Bonifacio M, Gozzini A, Martino B, Sora F, Westerweel PE, Fazi P, Vignetti M, Pane F, Breccia M. PMID: 40936723 [PubMed - in process]
	Prognostic discussions in patients with advanced lymphoma: Characteristics and challenges. Palliat Support Care McDarby M, Gilliland J, Dolma R, Rutherford SC, Martin P, Prigerson H, McConnell KM. PMID: 40936192 [PubMed - in process]
	Real-World Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma. Crit Rev Oncol Hematol Wang H, Li J, Cao L, Zhang Y, Wan X, Wang X, Li Z, Wang B, Bai O. PMID: 40935174 [PubMed - as supplied by publisher]
	Hemostatic evaluation in dogs with lymphoma - Systematic review. Res Vet Sci Gorenstein TG, Pimentel PAB, de Oliveira Paes Leme F, Duarte RCF, Dos Santos Horta R. PMID: 40934825 [PubMed - as supplied by publisher]
	Real-world cardiovascular risks of ibrutinib in chronic lymphocytic leukemia: a retrospective study. Front Oncol Ivanovic J, Otasevic V, Markovic K, Vukovic V, Bibic T, Tomic Vujovic K, Kozarac S, Vladicic Masic J, Milic N, Kulic J, Antic D. PMID: 40933891 [PubMed - in process]
	Chavez JC, Dickinson M, Munoz J, et al. Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study. Blood. 2025;145(20):2303-2311. Blood PMID: 40932739 [PubMed - in process]
	Pitfalls and artifacts in [18F]-FDG PET imaging in children with lymphoma. Q J Nucl Med Mol Imaging Albano D, Rizzo A, Rodella C, Panareo S, Guerra L. PMID: 40932703 [PubMed - as supplied by publisher]
	Primary cardiac lymphoma initially suspected as device-associated thrombus: a multimodal imaging diagnosis. Intensive Care Med Zhang Y, Yasheng Z, Sun Z, Zhang Z. PMID: 40932496 [PubMed - as supplied by publisher]
	Dissecting infant leukemia developmental origins with a hemogenic gastruloid model. Elife Ragusa D, Suen CW, Torregrosa Cortes G, Pastorino F, Johns A, Cicirò Y, Dijkhuis L, van den Brink S, Cilli M, Byrne C, Ionescu GA, Cerveira J, Kranc KR, Hernandez-Hernandez V, Ponzoni M, Bigas A, Garcia-Ojalvo J, Martínez Arias A, Pina C. PMID: 40932369 [PubMed - indexed for MEDLINE]
	Immunosenescence phenotypes and prognostic significance of CD8â€‰+â€‰CD28- T cells in AIDS-related non-Hodgkin lymphoma. Ann Med Kang Z, Tao X, Wu S, Chu S, Peng J, Chen J. PMID: 40932058 [PubMed - indexed for MEDLINE]
	Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma. Cancer Tan S, He H, Ni J, Guo Y, Wang H, Cai Z, Shang M, Cao Y, Li Y, Chen Y, Zhao H, Su L, Hu R, Chang X, Sun W. PMID: 40931981 [PubMed - indexed for MEDLINE]
	Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia. Cytometry B Clin Cytom Saraiva CMA, Moraes CRP, Duarte BKL, Oliveira GB, Sales Filho HLA, de Melo Campos P, Saad STO, De Paula EV. PMID: 40931755 [PubMed - as supplied by publisher]
	Commentary on: 2024 EURAPS expert consensus on Breast Implant Associated Anaplastic Large Cell Lymphoma. J Plast Reconstr Aesthet Surg Turton P. PMID: 40930914 [PubMed - as supplied by publisher]
	Validation of Cure Assumptions when Analyzing ZUMA-7 Follow-up Data of Axicabtagene Ciloleucel and Standard of Care Therapy in Second-Line Relapsed/Refractory Large B-cell Lymphoma. Transplant Cell Ther Perales MA, Oluwole OO, Patel AR, Ray MD, Rodriguez-Guadarrama YA, Smith NJ, Blissett R, Yang Y, Locke FL. PMID: 40930226 [PubMed - as supplied by publisher]
	Deciphering the molecular landscape of acute myeloid leukemia initiation and relapse: a systems biology approach. Med Oncol Bahmei A, Fadakar H, Tamaddon G. PMID: 40928707 [PubMed - indexed for MEDLINE]
	Novel Prognostic Scoring Systems for Severe CRS after Anti-CD19 CAR-T-Cells in Acute B-Lymphoblastic Leukemia. Curr Med Sci Ke S, Zhang TY, Wu ZL, Xie W, Liu L, Du MY. PMID: 40928684 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 160651

Seite 1 von 8033

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung